Celsee Diagnostics provides automated label-free platforms for circulating tumor cell (CTC) enrichment and analysis. The simple-to-use PREP platform uses whole blood and performs all the processing steps to detect, enrich and execute downstream single-cell analysis, including immunochemistry, DNA FISH and mRNA FISH. CTCs can be isolated for PCR and NGS applications. The add-on ANALYZER imaging station scans and analyzes the prepared slides.
Horizon Diagnostics, a business unit of Horizon Discovery Group plc, is a leading provider of genetically defined, human genomic reference standards, including FFPE cell line sections and purified genomic DNA. HDx™ Reference Standards offer a sustainable source of reference material to laboratories, proficiency schemes and manufacturers, providing an unprecedented level of control.
Personal Genome Diagnostics (PGDx) advances the frontiers of cancer medicine through innovative genomic technologies for oncology researchers, drug developers, clinicians and patients. The expert team at PGDx draws on a deep understanding of cancer biology and extensive experience in cancer genomics and clinical oncology to pioneer genomic methods. These novel technologies precisely identify and characterize unique genomic alterations in tumors.
At Precision for Medicine, we help our pharmaceutical and life sciences clients innovate, develop, and commercialize next generation medical products. Backed by a diverse team ofexperts across the spectrum of the healthcare marketplace, we provide a comprehensive and integrated set of services that help accelerate research, enable market adoption, enhancepatient outcomes, and realize the full commercial potential of new therapies and products.